In recent news, UnityPoint Health-Grinnell has introduced a revolutionary Neoprobe Gamma Detection System technology by Mammotome to their breast cancer diagnosis and treatment process. Dr. Anna Mensing, a general and breast surgeon at the Grinnell General Surgery and Weight Loss Surgery Clinic, is utilizing this technology to provide her patients with a more precise and personalized approach to their cancer care.
The Neoprobe is an advanced imaging device that helps surgeons locate cancerous tissue during surgery, providing a clearer picture of affected tissue tumors and improved diagnosis and treatment planning for breast cancer patients. By using this technology, surgeons can pinpoint cancerous tissue with greater accuracy, resulting in less invasive surgeries and lower complications for patients. Additionally, the Neoprobe allows for a more personalized treatment plan tailored to each patient’s specific needs.
At UnityPoint Health-Grinnell, they emphasize the importance of convenient access to high-quality healthcare for their patients. By offering the Neoprobe technology locally, patients can receive advanced care close to home, reducing stress and travel burdens. This new addition to their surgical team ensures that patients receive the best possible care while minimizing disruptions in their daily lives.
For more information on how the Neoprobe Gamma Detection System technology can benefit breast cancer patients, individuals can speak with their primary care provider or contact the UnityPoint Health-Grinnell General Surgery and Weight Loss Surgery Clinic at 641-236-4323.